Quality of life and α-blocker therapy: an important consideration for both the patient and the physician
- 28 February 2002
- Vol. 59 (2) , 7-11
- https://doi.org/10.1016/s0090-4295(01)01556-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Sexual Function in 1,202 Aging Males: Differentiating AspectsThe Journals of Gerontology: Series A, 1999
- 5-YEAR OUTCOME OF SURGICAL RESECTION AND WATCHFUL WAITING FOR MEN WITH MODERATELY SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA: A DEPARTMENT OF VETERANS AFFAIRS COOPERATIVE STUDYJournal of Urology, 1998
- Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaireBJU International, 1997
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- The ICS–‘BPH’ Study: the psychometric validity and reliability of the ICSmale questionnaireBritish Journal of Urology, 1996
- A brief male sexual function inventory for urologyUrology, 1995
- Benign Prostatic Hyperplasia Specific Health Status Measures in Clinical Research: How Much Change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is Perceptible to Patients?Published by Wolters Kluwer Health ,1995
- The Value of a New Symptom Score (DAN-PSS) in Diagnosing Uro-Dynamic Infravesical Obstruction in BPHScandinavian Journal of Urology and Nephrology, 1993
- Validation of a new quality of life questionnaire for benign prostatic hyperplasiaJournal of Clinical Epidemiology, 1992
- The American Urological Association Symptom Index for Benign Prostatic HyperplasiaJournal of Urology, 1992